1. Park UC, Kim SJ, Hwang JM, Yu YS. Clinical features and natural history of acquired third, fourth, and sixth cranial nerve palsy. Eye (Lond). 2008;22(5):691-696. doi:10.1038/sj.eye.6702720
2. Liu H, Tan N, Xu D, Li CY, Xian GJ. NGF and CNTF expression and regulation mechanism by miRNA in acute paralytic strabismus. Int Ophthalmol. 2020;40(4):975-984. doi:10.1007/s10792-019-01270-x
3. Kim M, Lew H. Binocular visual rehabilitation in paralytic strabismus by Botulinum A toxin chemodenervation. Korean J Ophthalmol. 2022; 36(1):60-65. doi:10.3341/kjo.2021.0054
4. Azizah ARN, Loebis R, Hidayati HB, Wahyuni I, Wulandari LR. The etiology of paralytic strabismus at an Indonesian tertiary hospital from 2017 to 2022. Folia Medica Indones.2024;60(1):8-16. doi:10.20473/fmi.v60i1.52036
5. Martinez-Thompson JM, Diehl NN, Holmes JM, Mohney BG. Incidence, types, and lifetime risk of adult-onset strabismus. Ophthalmology. 2014;121(4):877-882. doi:10.1016/j.ophtha.2013.10.030
6. Atilla H. Diagnostic modalities in paralytic strabismus.Turk Klin Ophthalmol Spec Topics.2014;7(3):38-44.
7. Kim JH, Choi HY, Jeon H. Clinical characteristics for predicting recovery of acquired fourth cranial nerve palsy. J Neuroophthalmol. 2022;42(2):234-238. doi:10.1097/WNO.0000000000001426
8. Gezer A. Paralitik şaşılıklar. 4. sinir felçleri. TOD Eğitim Yayınları Şaşılık Kitabı; 2008. s.185-191.
9. Holmes JM, Mutyala S, Maus TL, Grill R, Hodge DO, Gray DT. Pediatric third, fourth, and sixth nerve palsies: a population-based study. Am J Ophthalmol. 1999;127(4):388-392. doi:10.1016/s0002-9394 (98)00424-3
10. Bayramlar H, Aydın E, Totan Y, DağlıOğlu MC, Erten A. Which of the paralytic strabismus is most frequent? Abducens nerve palsy or trochlearis nerve palsy. Turk J Ophthalmol. 2000;30(2):188-191.
11. Söylev MF, Özkan SB, Kasım R, Duman S. The evaluation of etiological factors in 3rd, 4th and 6th cranial nerve palsies. Turk Clin J Ophthalmol. 1994;3(1):5-8.
12. Çakmak HB, Toprak B, Ozerdem U, Şener EC, Kansu T, Sanaç AŞ. Etiological factors in patients wıth paralytic strabismus. TOD XXX. Ulusal kongresi, Antalya, 877-883.
13. Çolpak, Aİ, Batur Çağlayan H. Isolated third, fourth, and sixth cranial nerve palsies in the Turkish population: etiologic factors and clinical course. Turk J Neurol.2019;25(1):032-035. doi:10.4274/tnd.2019.29795
14. Park KA, Oh SY, Min JH, Kim BJ, Kim Y. Acquired onset of third, fourth, and sixth cranial nerve palsies in children and adolescents. Eye (Lond). 2019;33(6):965-973. doi:10.1038/s41433-019-0353-y
15. Anand N, Gupta J, Gupta R. Study of clinico-etiological profile of patients with paralytic and restrictive strabismus.IP Int J Ocul Oncol Oculoplasty. 2020;6(1):48-54. doi:10.18231/j.ijooo.2020.009
16. Priya S, Guha S, Mittal S, Sharma S, Alam MS. Pediatric ocular motor cranial nerve palsy: demographics and etiological profile. Indian J Ophthalmol. 2021;69(5):1142-1148. doi:10.4103/ijo.IJO_1803_20
17. Meyer E, Ludatscher RM, Zonis S. Primary and secondary overacting inferior oblique muscles: an ultrastructural study. Br J Ophthalmol. 1984;68(6):416-420. doi:10.1136/bjo.68.6.416
18. Metz HS, Dickey CF. Treatment of unilateral acute sixth-nerve palsy with Botulinum toxin. Am J Ophthalmol. 1991;112(4):381-384. doi:10. 1016/s0002-9394(14)76243-9
19. Holmes JM, Beck RW, Kip KE, Droste PJ, Leske DA. Botulinum toxin treatment versus conservative management in acute traumatic sixth nerve palsy or paresis. J AAPOS. 2000;4(3):145-149.